A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer

BACKGROUND: Infusional fluorouracil/leucovorin (FU/LV) plus irinotecan (FOLFIRI) is one of the standard first-line options for patients with metastatic colorectal cancer (mCRC). Irinotecan is converted into 7-ethyl-10-hydroxycamptothecin (SN-38) by a carboxylsterase and metabolised through uridine d...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcuello, E, Páez, D, Paré, L, Salazar, J, Sebio, A, del Rio, E, Baiget, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137420/
https://www.ncbi.nlm.nih.gov/pubmed/21654688
http://dx.doi.org/10.1038/bjc.2011.206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137420/
https://www.ncbi.nlm.nih.gov/pubmed/21654688
http://dx.doi.org/10.1038/bjc.2011.206

Ejemplares similares